autosomal dominant polycystic kidney disease therapeutics (Goldfinch Bio)

N/A

Report date: 2025/03/14 16:39:21
NME

Base Information

Drug Nameautosomal dominant polycystic kidney disease therapeutics (Goldfinch Bio)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPolycystic Kidney, Autosomal Dominant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGoldfinch Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesGoldfinch Bio Inc
Inactive CompaniesN/A
Active IndicationsPolycystic Kidney, Autosomal Dominant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A